Table 4.
Associations between GrimAge measurements at Y15–Y20 and incident T2D during Y15–Y30 by BMI status at Y15
Normal weight at Y15 (BMI <25 kg/m2, N = 315) | Overweight at Y15 (BMI 25–30 kg/m2, N = 365) | With obesity at Y15 (BMI ≥30 kg/m2, N = 287) | Pinteraction | |
---|---|---|---|---|
Model 1: diabetes vs. prediabetes and normal glucose | ||||
Chronological age | 1.21 (1.02–1.44)* | 1.04 (0.93–1.17) | 0.99 (0.92–1.07) | 0.54 |
GrimAge† | 1.01 (0.91–1.11) | 1.03 (0.98–1.08) | 1.01 (0.97–1.05) | 0.13 |
GrimAA† | 0.92 (0.81–1.05) | 1.03 (0.96–1.09) | 1.01 (0.96–1.07) | 0.17 |
Positive GrimAA | 0.71 (0.21–2.44) | 1.13 (0.60–2.14) | 1.71 (1.12–2.60)* | 0.69 |
Positive 5yr GrimAA | 0.64 (0.19–2.13) | 0.70 (0.38–1.28) | 1.86 (1.24–2.79)** | <0.01 |
Model 2: diabetes vs. normal glucose (prediabetes excluded) | ||||
Chronological age | 1.26 (1.06–1.51)** | 1.05 (0.93–1.19) | 1.02 (0.93–1.11) | 0.56 |
GrimAge | 1.03 (0.93–1.13) | 1.03 (0.97–1.09) | 1.01 (0.97–1.06) | 0.06 |
GrimAA | 0.94 (0.83–1.07) | 1.02 (0.96–1.09) | 0.99 (0.93–1.06) | 0.03 |
Positive GrimAA | 0.89 (0.25–3.14) | 1.12 (0.56–2.25) | 2.10 (1.29–3.41)* | 0.54 |
Positive 5yr GrimAA | 0.65 (0.19–2.20) | 0.70 (0.37–1.34) | 1.90 (1.21–2.98)** | <0.01 |
Model 3: hyperglycemia (diabetes or prediabetes) vs. normal glucose | ||||
Chronological age | 1.17 (1.10–1.24)*** | 1.02 (0.96–1.09) | 1.04 (0.97–1.11) | 0.10 |
GrimAge | 1.06 (1.02–1.10)** | 1.02 (0.99–1.05) | 1.00 (0.97–1.04) | <0.01 |
GrimAA | 1.02 (0.97–1.08) | 1.03 (0.99–1.07) | 0.97 (0.92–1.02) | <0.01 |
Positive GrimAA | 1.60 (1.01–2.56)* | 1.21 (0.85–1.73) | 1.39 (0.96–2.00) | 0.12 |
Positive 5yr GrimAA | 1.54 (1.05–2.25)* | 1.65 (1.21–2.25)* | 1.26 (0.88–1.79) | 0.71 |
Data are OR (95% CI). Models are adjusted for race, sex, education, smoking status, physical activity, alcohol drinking, and field center.
For GrimAge and GrimAA, the ORs and 95% CIs were calculated based on 1-year increase of each measurement.
P < 0.05;
P < 0.01;
P < 0.001.